T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes
- 31 March 2004
- journal article
- review article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 22 (2) , 121-129
- https://doi.org/10.1016/j.jaut.2003.10.003
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- CD154-Dependent Priming of Diabetogenic CD4+ T Cells Dissociated from Activation of Antigen-Presenting CellsImmunity, 2002
- A Mechanism for the Major Histocompatibility Complex–linked Resistance to AutoimmunityThe Journal of Experimental Medicine, 1997
- Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouseInternational Immunology, 1995
- The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetesEuropean Journal of Immunology, 1993
- Collaboration of helper and cytotoxic T lymphocytesEuropean Journal of Immunology, 1993
- Multiple levels of peripheral toleranceImmunology Today, 1993
- Studies on autoimmunity for T-cell-mediated beta-cell destruction. Distinct difference in beta-cell destruction between CD4+ and CD8+ T-cell clones derived from lymphocytes infiltrating the islets of NOD miceDiabetes, 1992
- Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune responseCell, 1991
- Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic miceCell, 1991
- Transgenic Mice with I-A on Islet Cells Are Normoglycemic But Immunologically IntolerantScience, 1989